CTA spot sign predicts hematoma expansion in patients with delayed presentation after intracerebral hemorrhage

Neurocritical Care

Volumn 17, Issue 3, 2012, Pages 421-428

  Brouwers, H Bart ^a   Falcone, Guido J ^a   McNamara, Kristen A ^a   Ayres, Alison M ^a   Oleinik, Alexandra ^a   Schwab, Kristin ^a   Romero, Javier M ^a   Viswanathan, Anand ^a   Greenberg, Steven M ^a   Rosand, Jonathan ^a   Goldstein, Joshua N ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

CT angiography; CTA spot sign; Hematoma expansion; Intracerebral hemorrhage; Late presentation

Indexed keywords

ANTITHROMBOCYTIC AGENT; WARFARIN;

AGE; AGED; ARTICLE; BRAIN HEMATOMA; BRAIN HEMATOMA EXPANSION; BRAIN HEMORRHAGE; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; DIAGNOSTIC ACCURACY; DISEASE SEVERITY; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PRIORITY JOURNAL; RADIOLOGICAL PARAMETERS; SENSITIVITY AND SPECIFICITY; SEX DIFFERENCE; SPOT SIGN; SYSTOLIC BLOOD PRESSURE; BRAIN ANGIOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; DELAYED DIAGNOSIS; DISEASE COURSE; METHODOLOGY; MIDDLE AGED; PREVALENCE; PROSPECTIVE STUDY; RADIOGRAPHY; REPRODUCIBILITY; RETROSPECTIVE STUDY; RISK FACTOR; STANDARD; VALIDATION STUDY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CEREBRAL ANGIOGRAPHY; CEREBRAL HEMORRHAGE; DELAYED DIAGNOSIS; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PREVALENCE; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; RISK FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84878180065     PISSN: 15416933     EISSN: 15560961     Source Type: Journal    
DOI: 10.1007/s12028-012-9765-2     Document Type: Article

References (23)

1. Qureshi AI, Tuhrim S, Broderick JP, Batjer HH, Hondo H, Hanley DF. Spontaneous intracerebral hemorrhage. N Engl J Med. 2001;344:1450-60. (Pubitemid 32402103)
2. van Asch CJ, Luitse MJ, Rinkel GJ, van der Tweel I, Algra A, Klijn CJ. Incidence, case fatality, and functional outcome of intracerebral haemorrhage over time, according to age, sex, and ethnic origin: a systematic review and meta-analysis. Lancet Neurol. 2010;9:167-76.
3. Broderick JP, Brott TG, Duldner JE, Tomsick T, Huster G. Volume of intracerebral hemorrhage. A powerful and easy-to-use predictor of 30-day mortality. Stroke. 1993;24:987-93. (Pubitemid 23201455)
4. Davis SM, Broderick J, Hennerici M, et al. Hematoma growth is a determinant of mortality and poor outcome after intracerebral hemorrhage. Neurology. 2006;66:1175-81. (Pubitemid 43739699)
5. Dowlatshahi D, Demchuk AM, Flaherty ML, et al. Defining hematoma expansion in intracerebral hemorrhage: relationship with patient outcomes. Neurology. 2011;76:1238-44.
6. Mayer SA, Brun NC, Begtrup K, et al. Recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med. 2005;352:777-85. (Pubitemid 40271172)
7. Mayer SA, Brun NC, Begtrup K, et al. Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med. 2008;358:2127-37. (Pubitemid 351679599)
8. Anderson CS, Huang Y, Wang JG, et al. Intensive blood pressure reduction in acute cerebral haemorrhage trial (INTERACT): a randomised pilot trial. Lancet Neurol. 2008;7:391-9.
9. Delcourt C, Huang Y, Wang J, et al. The second (main) phase of an open, randomised, multicentre study to investigate the effectiveness of an intensive blood pressure reduction in acute cerebral haemorrhage trial (INTERACT2). Int J Stroke. 2010;5:110-6.
10. Qureshi AI, Palesch YY. Antihypertensive treatment of acute cerebral hemorrhage (ATACH) II: design, methods, and rationale. Neurocrit Care. 2011;15:559-76.
11. Aviv RI, Gladstone D, Goldstein J, et al. Contrast extravasation predicts hematoma growth: where to now? AJNR Am J Neuroradiol. 2008;29:E80.
12. Goldstein JN, Fazen LE, Snider R, et al. Contrast extravasation on CT angiography predicts hematoma expansion in intracerebral hemorrhage. Neurology. 2007;68:889-94. (Pubitemid 46568499)
13. Wada R, Aviv RI, Fox AJ, et al. CT angiography "spot sign" predicts hematoma expansion in acute intracerebral hemorrhage. Stroke. 2007;38:1257-62. (Pubitemid 351664234)
14. Demchuk AM, Dowlatshahi D, Rodriguez-Luna D, et al. Prediction of haematoma growth and outcome in patients with intracerebral haemorrhage using the CT-angiography spot sign (PREDICT): a prospective observational study. Lancet Neurol. 2012;11:307-14.
15. Kim J, Smith A, Hemphill JC 3rd, et al. Contrast extravasation on CT predicts mortality in primary intracerebral hemorrhage. AJNR Am J Neuroradiol. 2008;29:520-5. (Pubitemid 351424067)
16. Li N, Wang Y, Wang W, et al. Contrast extravasation on computed tomography angiography predicts clinical outcome in primary intracerebral hemorrhage: a prospective study of 139 cases. Stroke. 2011;42:3441-6.
17. Delgado Almandoz JE, Yoo AJ, Stone MJ, et al. Systematic characterization of the computed tomography angiography spot sign in primary intracerebral hemorrhage identifies patients at highest risk for hematoma expansion: the spot sign score. Stroke. 2009;40:2994-3000.
18. Delgado Almandoz JE, Yoo AJ, Stone MJ, et al. The spot sign score in primary intracerebral hemorrhage identifies patients at highest risk of in-hospital mortality and poor outcome among survivors. Stroke. 2010;41:54-60.
19. Brott T, Broderick J, Kothari R, et al. Early hemorrhage growth in patients with intracerebral hemorrhage. Stroke. 1997;28:1-5. (Pubitemid 27039454)
20. Brouwers HB, Biffi A, Ayres AM, et al. APOE genotype predicts hematoma expansion in lobar intracerebral hemorrhage. Stroke. 2012;43:1490-5.
21. Mayer SA. Ultra-early hemostatic therapy for intracerebral hemorrhage. Stroke. 2003;34:224-9. (Pubitemid 36070827)
22. Wardlaw JM. Prediction of haematoma expansion with the CTA spot sign: a useful biomarker? Lancet Neurol. 2012;11:294-5.
23. Mayer SA, Davis SM, Skolnick BE, et al. Can a subset of intracerebral hemorrhage patients benefit from hemostatic therapy with recombinant activated factor VII? Stroke. 2009;40:833-40.